A high-calibre advisory board supports 55pharma in all scientific matters in the fields of endocrinology, dermatology, neurology, pharmacology, plant chemistry, and pharmacognosy.
- Prof. Dr. Clemens Fürnsinn, Associate Professor of Metabolic Physiology at the Department of Internal Medicine III, Medical University of Vienna (Vienna General Hospital), Austria
- Prof. Dr. Gerhard Schlüter, former Member of the Board of Directors and Global Head of Toxicology, BAYER AG
- Prof. Dr. Eugen J. Verspohl, Professor at the Department of Pharmacology at the Institute of Medicinal and Pharmaceutical Chemistry, University of Münster, Germany
- Prof. Dr. Andreas Pfützner, CEO Institute for Clinical Research and Development, Germany; Professor for Applied Clinical Sciences, Bonn-Rhein-Sieg, Germany
- Prof. Dr. Tibor Rozman, Associate Professor at the Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, USA and independent consultant in pharmacology, toxicology, clinical trials, and drug safety; former Medical Director and Vice President for Research and Development, Basotherm GmbH (Boehringer Ingelheim Group), Biberach a. d. Riss, Germany
- Prof. Dr. Malcolm. Lader, O.B.E., D.Sc., Ph.D., M.D., F.R.C. Psych., F. Med. Sci, Emeritus Professor of Clinical Psychopharmacology at the Institute of Psychiatry, Kings College London, University of London, United Kingdom
- Prof. Dr. Beatrix Volc-Platzer, Head of the Dermatology Department at the Donauspital/SMZ-Ost, Vienna, Austria
- Prof. Dr. Markus Müller, Professor and Chairman of the Department of Clinical Pharmacology, Medical University of Vienna (Vienna General Hospital) (also member of the supervisory board)
55pharmaDrug Discovery & Development AGPalais Pálffy, Josefsplatz 61010 Vienna, AustriaTZT, Technopark 13430 Tulln, AustriaPhone:Fax:Email: